NbP45, one of our new anti-PD-1 nanobodies which was isolated from an alpaca immunized with human PD-1, inhibited SFTSV infection of PBMCs through reducing apoptosis and enhancing the proliferation of T lymphocytes. This evidence concerns the gene PDCD1 and infection.